MapLight Therapeutics, Inc. (MPLT) stock
MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.90−0.35 (-4.83%)
Close on Nov 16, 2026Market cap $320.01MP/E –Yield –
MapLight Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
MapLight Therapeutics's enterprise value was $35.14M on Nov 11, 2026, against -$216.19M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $35.14M | – |
| 2025 | Dec 31, 2025 | -$213.01M | – |
See a number that looks wrong?